For IHN, Estonia and Finland have submitted to the Commission information demonstrating that the conditions for the approval of disease-free status from IHN laid down in Delegated Regulation (EU) 2020/689 are fulfilled for the whole of the territory and for a compartment respectively. Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Part II, Chapter 4, of Delegated Regulation (EU) 2020/689 for the granting of disease-free status from IHN. Therefore, the whole territory of Estonia and one compartment in Finland should be listed in Part I of Annex XIII to Implementing Regulation (EU) 2021/620, as having disease-free status from IHN.
Recital 10, Regulation (EU) 2024/1332
In forcesince 17 May 2024